HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: Design of a cost-effectiveness randomised controlled trial

BMC Endocrine Disorders

Volumn 15, Issue 1, 2015, Pages

  Rondags, Stefanie M P A ^a   de Wit, Maartje ^a   van Tulder, Maurits W ^a   Diamant, Michaela ^a   Snoek, Frank J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; INSULIN;

ADULT; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EUROQOL 5 DIMENSIONAL 5 LEVEL VERSION QUESTIONNAIRE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; HYPOGLYCEMIA; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PSYCHOEDUCATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; ADOLESCENT; ANXIETY; AWARENESS; CHEMICALLY INDUCED; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEPRESSION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ECONOMICS; FEMALE; GROUP THERAPY; HEALTH CARE COST; INTERNET; MALE; MENTAL STRESS; MULTICENTER STUDY; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY; AWARENESS; COST-BENEFIT ANALYSIS; DEPRESSION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTERNET; MALE; NETHERLANDS; PATIENT EDUCATION AS TOPIC; PSYCHOTHERAPY, GROUP; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84939530468     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/s12902-015-0035-0     Document Type: Article

References (19)

1. Unger J, Parkin C. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance. Postgrad Med. 2011;123:81-91.
2. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: A report of aworkgroup of the American diabetes association and the endocrine society. Diabetes Care. 2013;36:1384-95.
3. Oyer S. The science of hypoglycemia in patients with diabetes. Curr Diabetes Rev. 2013;9:195-208.
4. Ha WC, Oh SJ, Kim JH, Lee JM, Chang SA, Sohn TS, et al. Severe hypoglycemia is a serious complication and becoming an economic burden in diabetes. Diabetes Metabol J. 2012;36:280-4.
5. Cox DJ, Gonder-Frederick L, Ritterband L, Patel K, Schächinger H, Fehm-Wolfsdorf G, et al. Blood glucose awareness training: what is it, where is it, and where is it going? Diabetes Spectrum. 2006;19:43-9.
6. Gonder-Frederick L, Cox D, Kovatchev B, Schlundt D, Clarke W. A biopsychobehavioral model of risk of severe hypoglycemia. Diabetes Care. 1997;20:661-9.
7. Nederlandse Diabetes Federatie. NDF Zorgstandaard Addendum Diabetes type 1. http://www.zorgstandaarddiabetes.nl. 2009. 8-6-2015. Ref Type: Online Source
8. Gold AE, Macleod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697-703.
9. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517-22.
10. Gonder-Frederick LA, Schmidt KM, Vajda KA, Greear ML, Singh H, Shepard JA, et al. Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes. Diabetes Care. 2011;34:801-6.
11. McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, et al. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia. 2010;53:66-9.
12. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.
13. Van der Ven NC, Weinger K, Yi J, Pouwer F, Adèr H, Van Der Ploeg HM, et al. The Confidence in Diabetes Self-Care Scale Psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care. 2003;26:713-8.
14. Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5 L). Qual Life Res. 2011;20:1727-36.
15. Hakkaart-van Roijen L, Van Straten A, Donker M, Tiemens B. Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TIC-P). 2002. Institute for Medical Technology Assessment, Erasmus University Rotterdam Trimbos.
16. Schachinger H, Hegar K, Hermanns N, Straumann M, Keller U, Fehm-Wolfsdorf G, et al. Randomized controlled clinical trial of blood glucose awareness training (BGAT III) in Switzerland and Germany. J Behav Med. 2005;28:587-94.
17. Twisk JW: Applied multilevel analysis: a practical guide for medical researchers. Cambridge, UK: Cambridge University Press; 2006
18. Geddes J, Wright RJ, Zammitt NN, Deary IJ, Frier BM. An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care. 2007;30:1868-70.
19. Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev. 2003;19:232-40.